(Q37001957)

17 August 2017

Trisomy 21 enhances human fetal erythro-megakaryocytic development (English)

1 reference

17 August 2017

Stella T Chou

1

1 reference

17 August 2017

Joanna B Opalinska

2

1 reference

17 August 2017

Yu Yao

3

1 reference

17 August 2017

Myriam A Fernandes

4

1 reference

17 August 2017

Anna Kalota

5

1 reference

17 August 2017

John S J Brooks

6

1 reference

17 August 2017

John K Choi

7

1 reference

17 August 2017

Alan M Gewirtz

8

1 reference

17 August 2017

Gwenn-ael Danet-Desnoyers

9

1 reference

17 August 2017

Richard L Nemiroff

10

1 reference

17 August 2017

Mitchell J Weiss

11

1 reference

17 August 2017

language of work or name

English

0 references

publication date

23 September 2008

1 reference

17 August 2017

1 reference

17 August 2017

112

1 reference

17 August 2017

12

1 reference

17 August 2017

4503-4506

1 reference

Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

GATA1 in normal and malignant hematopoiesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Origins of leukaemia in children with Down syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Prospective isolation of human clonogenic common myeloid progenitors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

The management of neoplastic disorders of haematopoiesis in children with Down's syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Natural history of GATA1 mutations in Down syndrome

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2597125

Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome

4 September 2018

1 reference

12 December 2020

Expression of erythroid‐specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome

1 reference

12 December 2020

Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts

1 reference

12 December 2020

Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1

1 reference

12 December 2020

10.1182/BLOOD-2008-05-157859

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18812473

1 reference